None
Conditions
Interventions
Ingestion of food containing Bifidobacteria for 13 weeks
Ingestion of placebo for 13 weeks
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy men and women aged more than 20 years, less than 65 years. 2) Subject with a history of allergic nasal symptoms in the past 2 years. 3) Subject who is positive for cedar pollinosis-specific IgE (class 2 or higher).
Exclusion criteria
Exclusion criteria: 1) Subject who regularly take or took allergy medicine. 2) Subject with hepatic disease, renal dysfunction, cardiovascular disorder, gastrointestinal disorder, respiratory dysfunction, blood disease, autoimmune disease, endocrine disease, metabolic disease and these severe medical history (Excluding appendectomy). 3) Subject with serious allergy to specific medicine or food. 4) Subject who is pregnant or under lactation, or who is expected to be pregnant during the study. 5) Subject who takes part in other clinical study within the past month. 6) Subject who is ineligible due to physician's judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nasal symptom score (symptom score, medication score, symptom-medication score) | — |
Secondary
| Measure | Time frame |
|---|---|
| Japanese Rhino-conjunctivitis Quality of Life Questionnaire (Items related to the nose) | — |
Countries
Japan
Contacts
Public ContactEiji Yoshikawa
KSO Corporation President-director
Outcome results
None listed